These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 21682594)

  • 1. Designing the next generation of vaccines for global public health.
    Bagnoli F; Baudner B; Mishra RP; Bartolini E; Fiaschi L; Mariotti P; Nardi-Dei V; Boucher P; Rappuoli R
    OMICS; 2011 Sep; 15(9):545-66. PubMed ID: 21682594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing antibacterial vaccines in genomics and proteomics era.
    Kaushik DK; Sehgal D
    Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic testing for vaccinomics: is the regulatory approval framework adequate? A comparison of Canada, the United States, and Europe.
    Joly Y; Koutrikas G; Ramos-Paque E; Zawati M; Gardy J; Hayden MR; Carleton BC
    OMICS; 2011 Sep; 15(9):597-605. PubMed ID: 21728814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome- and proteome-wide screening strategies for antigen discovery and immunogen design.
    Schussek S; Trieu A; Doolan DL
    Biotechnol Adv; 2014; 32(2):403-14. PubMed ID: 24389084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinomics for the major blood feeding helminths of humans.
    Loukas A; Gaze S; Mulvenna JP; Gasser RB; Brindley PJ; Doolan DL; Bethony JM; Jones MK; Gobert GN; Driguez P; McManus DP; Hotez PJ
    OMICS; 2011 Sep; 15(9):567-77. PubMed ID: 21679087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing vaccines in the era of genomics: a decade of reverse vaccinology.
    Seib KL; Zhao X; Rappuoli R
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():109-16. PubMed ID: 22882709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics approaches towards antigen discovery and vaccine development.
    Klade CS
    Curr Opin Mol Ther; 2002 Jun; 4(3):216-23. PubMed ID: 12139306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens.
    Serruto D; Adu-Bobie J; Capecchi B; Rappuoli R; Pizza M; Masignani V
    J Biotechnol; 2004 Sep; 113(1-3):15-32. PubMed ID: 15380644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine adjuvant technology: from mechanistic concepts to practical applications.
    Degen WG; Jansen T; Schijns VE
    Expert Rev Vaccines; 2003 Apr; 2(2):327-35. PubMed ID: 12899582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of genomics on vaccine design.
    Scarselli M; Giuliani MM; Adu-Bobie J; Pizza M; Rappuoli R
    Trends Biotechnol; 2005 Feb; 23(2):84-91. PubMed ID: 15661345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New ways to identify novel bacterial antigens for vaccine development.
    Movahedi AR; Hampson DJ
    Vet Microbiol; 2008 Sep; 131(1-2):1-13. PubMed ID: 18372122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
    Perdue ML; Bright RA
    Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How the research-based industry approaches vaccine development and establishes priorities.
    André FE
    Dev Biol (Basel); 2002; 110():25-9. PubMed ID: 12477303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond epitopes: future and application of computational vaccinology.
    Söllner J
    Hum Vaccin; 2011 Jul; 7(7):795-7. PubMed ID: 21445008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Information technologies for vaccine research.
    Brusic V; August JT; Petrovsky N
    Expert Rev Vaccines; 2005 Jun; 4(3):407-17. PubMed ID: 16026252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of reverse vaccinology in Schistosoma vaccine development: advances and prospects].
    Feng XG; Sui CY; Yuan CX; Shao DH; Chen JX; Lin JJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):237-47. PubMed ID: 18038788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary approaches to designing and evaluating vaccines against Chlamydia.
    Igietseme JU; Eko FO; Black CM
    Expert Rev Vaccines; 2003 Feb; 2(1):129-46. PubMed ID: 12901604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.